论文部分内容阅读
67例淋巴增生性疾病(LPD),其中慢淋(CLL)20例,非何杰金氏淋巴瘤(NHL)37例,骨髓瘤(My)10例。146例自身免疫性疾病,其中系统性红斑狼疮(SLE)28例,类风湿性关节炎(RA)65例,恶性贫血(PA)40例,自身免疫性溶血性贫血(AIHA)13例。血小板计数(BPT)减少的病例均行骨髓检查及活检,并检查巨核细胞。排除由于浸润或抑制所引起的血小板减少。用定量酶联免疫法测定血小板相关IgG(PAIgG)。
There were 67 cases of lymphadenopathy (LPD), including 20 cases of chronic lymphocytic leukemia (CLL), 37 cases of non-Hodgkin’s lymphoma (NHL) and 10 cases of myeloma (My). 146 cases of autoimmune diseases, including 28 cases of systemic lupus erythematosus (SLE), 65 cases of rheumatoid arthritis (RA), 40 cases of pernicious anemia (PA) and 13 cases of autoimmune hemolytic anemia (AIHA). Patients with reduced platelet count (BPT) underwent bone marrow and biopsy and examined for megakaryocytes. Thrombocytopenia due to infiltration or inhibition is excluded. Platelet-associated IgG (PAIgG) was determined by quantitative enzyme-linked immunosorbent assay.